uniQure share price logo

uniQure

NASDAQ: QURE

Mid Cap

$48.05

+0.67

(+1.41%)

Live

as on

uniQure Stock Performance

as on August 20, 2026 at 2:10 am IST

  • Day's Low

    Day's High

    $46.93
    $48.34
    downward going graph

    2.33%

    Downside

    0.60%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.73
    $71.50
    downward going graph

    81.83%

    Downside

    48.80%

    Upside

    downward going graph

uniQure share price movements today

Previous Close
$47.38
Open
$48.00
Volume
379.8K
Market Cap
$3.4B
Day's Low - High
$46.93 - $48.34
52 Week Low - High
$8.73 - $71.50

uniQure Historical Returns

1 Month Return
+ 20.8 %
3 Month Return
+ 79.74 %
1 Year Return
+ 200.49 %
3 Year Return
+ 484.37 %
5 Year Return
+ 67.54 %

uniQure Stock Fundamentals & Key Indicators

Check uniQure market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.4B

EPS (TTM)

-4.04

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.18%

PE Ratio (TTM)

-11.65

Industry PE ratio

-13.046547619047619

PEG Ratio

1.1022533246897568

EBITDA

-181.1M

Revenue (TTM)

18.7M

Profit Margin

22.79%

Return On Equity TTM

-111.96%

uniQure Stock Valuation

Track how uniQure P/E has moved over time to understand its valuation trends.

uniQure in the last 5 years

  • Overview

  • Trends

Lowest (-8.36x)

December 31, 2022

Industry (-13.05x)

December 31, 2025

Today (-6.92x)

December 31, 2025

Highest (2.89x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -6.92x

uniQure vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of uniQure with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$3.4B67.54%-11.6522.79%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for uniQure Stock including INR - Dollar returns

The uniQure stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

uniQure investment value today

Current value as on today

₹3,26,553

Returns

₹2,26,553

(+226.55%)

Returns from uniQure Stock

₹1,96,972 (+196.97%)

Dollar Impact

₹29,581 (+29.58%)

Analyst Recommendation on uniQure Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for uniQure. Average target price of $69.69

uniQure Share Price Target

Get share price movements and forecasts by analysts on uniQure.

What analysts predicted

31.05%UPSIDE

Target Price

$69.69

Current Price

$48.05

Analyzed by

10 Analysts

Target

$69.69

uniQure target price $69.69, a slight upside of 31.05% compared to current price of $48.05. According to 10 analysts rating.

Indian Investors' Interest in uniQure Stock

Search interest for uniQure Stock has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-70% versus previous 30 day period

uniQure Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
8
11
2
5
1
5
3
5
3
5
Gross Profit
0
3
1
4
1
4
3
2
3
-4
Operating Income
-54
-44
-40
-45
-39
-43
-51
-52
-44
-55
EBITDA
-46
-36
-24
-53
-23
-18
-51
-23
-36
-69
Interest Expense
16
16
16
14
15
15
16
14
14
14
Depreciation
2
2
2
4
4
3
3
2
2
4
Income Before Tax
-64
-55
-44
-72
-43
-37
-71
-41
-53
-79
Income Tax Expense
0
0
0
0
0
0
8
-3
0
1
Net Income
-65
-56
-44
-73
-43
-37
-80
-37
-53
-81
Net Profit Margin
-8.73%
32.94%
55.36%
88.14%
87.43%
87.53%
89.25%
38.85%
93.85%
-77.97%

uniQure Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
13
11
7
37
524
106
15
27
16
Gross Profit
-54
-61
7
-84
499
103
2
8
14
Operating Income
-71
-88
-121
-125
310
-143
-282
-184
-187
EBITDA
-69
-74
-113
-126
319
-108
-253
-160
-116
Interest Expense
2
2
3
3
7
11
41
63
61
Depreciation
7
6
6
10
7
8
11
12
14
Income Before Tax
-80
-83
-124
-141
332
-128
-306
-237
-193
Income Tax Expense
0
0
-
-16
3
-1
1
2
5
Net Income
-80
-83
-124
-125
329
-126
-308
-239
-198
Net Profit Margin
-414.30%
-547.47%
100.00%
-226.28%
95.23%
96.86%
13.98%
32.42%
89.53%

uniQure Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-65
-56
-44
-73
-43
-37
-80
-37
-53
-81
Operating Cash Flow
-60
-32
-36
-52
-44
-39
-16
-77
-38
-28
Investing Cash Flow
63
77
47
-26
20
73
26
-456
98
53
Financing Cash Flow
-
0
-53
-6
80
0
332
-3
0
249
Change in Cash
1
44
-37
-92
58
36
343
-516
59
273

uniQure Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-80
-83
-124
-125
329
-126
-308
-239
-198
Operating Cash Flow
-64
-76
-98
-134
287
-145
-145
-182
-177
Investing Cash Flow
-6
-4
-6
-9
-67
-182
-205
162
-321
Financing Cash Flow
90
157
248
7
94
1
362
-59
415
Change in Cash
26
75
143
-133
311
-328
13
-84
-78

Mutual Funds that own uniQure Stock

Check out the Mutual Funds with significant holdings in uniQure.

Funds
Holdings
Shares Held
Fidelity Select Portfolios
2.733109%
1895860
Delaware Group Equity Funds IV
1.762507%
1222588
JPMorgan Trust II
1.366694%
948027
VANGUARD INDEX FUNDS
1.000993%
694353
Fidelity Concord Street Trust
0.898084%
622969

Global Institutional Holdings in uniQure

Funds
Holdings
SPDR
3.57%
Vanguard
1.3%
iShares
1.04%
Lee Ainslie
1.01%
JPMorgan
0.74%

uniQure News & Key Events

  • img

    Today's Timeline - 18 June

    Thu, 07:05 PM

    -

    Barclays upgrades uniQure to Overweight, raising price target to $65 after FDA's regulatory update for Huntington's therapy.

    Fri, 03:57 AM

    -

    uniQure's AMT-130 receives FDA's accelerated approval pathway, lifting regulatory overhang and boosting stock significantly.

Insights on uniQure

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, QURE stock has moved up by 91.9%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.56M → 5.84M (in $), with an average increase of 39.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 629.2% return, outperforming this stock by 182.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 491.1% return, outperforming this stock by 282.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -37.08M → -81.05M (in $), with an average decrease of 47.9% per quarter

About uniQure

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
OrganisationuniQure
HeadquartersPaasheuvelweg 25, Amsterdam, Netherlands, 1105 BP
IndustryBiotechnology
CEOMr. Matthew Craig Kapusta CPA
E-voting on sharesClick here to vote

Key Management of uniQure

Name

Title

Dr. Jeannette Potts J.D., Ph.D.

Chief Legal & Compliance Officer and Corporate Secretary

Dr. Walid Abi-Saab M.D.

Chief Medical Officer

Mr. Richard Porter Ph.D.

Chief Business & Scientific Officer

Dr. Tamara Tugal Ph.D., MBA

Business Development Director

Mr. Christian Klemt

CFO, Principal Financial Officer & GM of Amsterdam Site

Prof. Hugo Katus

Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany

Dr. Amin Abujoub Ph.D.

Chief Technical Operations Officer

Ms. Chiara Elizabeth Russo

Senior Director of Investor Relations

Ms. Erin Boyer

Chief People & Culture Officer

Mr. Matthew Craig Kapusta CPA

CEO & Executive Director

FAQs

What is uniQure share price today?

uniQure share price today is $48.05 as on . uniQure share today touched a day high of $48.34 and a low of $46.93.

What is the 52 week high and 52 week low for uniQure share?

uniQure share touched a 52 week high of $71.50 on and a 52 week low of $8.73 on . uniQure stock price today i.e. is trending at $48.05,which is 32.80% down from its 52 week high and 450.40% up from its 52 week low.

What is uniQure's market capitalisation today?

uniQure market capitalisation is $0.00T as on .

How to invest in uniQure Stock (QURE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for uniQure on INDmoney app. Click on Buy button. You can invest as low as $1.5 in uniQure Shares that will get you 0.0312 shares as per uniQure share price of $48.05 per share as on August 19, 2026 at 8:40 pm IST.

What is the minimum amount required to buy uniQure Stock (QURE) from India?

Indian investors can start investing in uniQure (QURE) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in uniQure stock (as per the Rupee-Dollar exchange rate as on ). Based on uniQure share’s latest price of $48.05 as on August 19, 2026 at 8:40 pm IST, you will get 0.2081 shares of uniQure. Learn more about fractional shares .

What are the returns that uniQure has given to Indian investors in the last 5 years?

uniQure stock has given 67.54% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?